Today: 9 June 2026
Browse Category

NSE:ATGL 11 March 2026

India Stock Market Today: Nifty 50 Closes Below 23,900, Sensex Slides 1.7% as Oil Volatility Hits Banks

India Stock Market Today: Nifty 50 Closes Below 23,900, Sensex Slides 1.7% as Oil Volatility Hits Banks

India’s Nifty 50 fell 1.63% to 23,866.85 and the Sensex dropped 1.72% to 76,863.71 on Wednesday as oil prices surged and Middle East tensions deepened. Twelve of 16 major sectors declined, with HDFC Bank down 1.8% and Reliance Industries off 1.3%. The rupee weakened to 92.04 per dollar. Adani Total Gas jumped 20% after emergency gas measures were invoked.
11 March 2026
··········

Stock Market Today

  • MSG Holdings Sees Stock Surge as Knicks Reach NBA Finals
    June 9, 2026, 8:49 AM EDT. MSG Holdings' stock price hit record highs driven by the New York Knicks' unexpected run to the NBA Finals. The team's playoff success boosts investor confidence in MSG's sports and entertainment assets, highlighting the correlation between competitive performance and corporate valuation. Traders responded positively, reflecting optimism about increased revenue from game attendance, merchandise, and media rights. MSG's stock gains underscore the market's sensitivity to sports franchise performance as a business driver.

Latest articles

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Grab Stock Barely Moves As Taiwan Push And Singapore Merchant Plan Put Growth Back In Focus

Grab Stock Barely Moves As Taiwan Push And Singapore Merchant Plan Put Growth Back In Focus

9 June 2026
Grab shares hovered near $3.33 in pre-market trading after unveiling a new Singapore merchant programme and Taiwan partner commitments, as investors weigh growth initiatives against regulatory hurdles and consumer spending pressure; the stock’s muted move reflects ongoing uncertainty around its proposed foodpanda Taiwan acquisition and potential margin impacts from promotions.
CCSC stock pops ahead of the bell as Nasdaq deadline looms

CCSC stock pops ahead of the bell as Nasdaq deadline looms

9 June 2026
CCSC Technology International Holdings shares soared 315% to $1.99 in U.S. premarket trading, putting the microcap near Nasdaq’s $1 minimum bid price just days before a June 15 compliance deadline, but only a regular-session closing price above $1 counts toward regaining listing compliance.
Go toTop